Company
Ashvattha
Also known as Ashvattha Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Ashvattha Therapeutics is creating products that selectively target and treat human diseases. Through their patented hydroxyl dendrimer molecules, Ashvattha can target inflammation-causing macrophages without harming the surrounding cells, leading to greater efficacy than traditional free drug applications.
Loading relationship preview